Clinical Trial Update: Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical vitamin D3, diclofenac, or their combination for basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Diclofenac (diclofenac)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED